US-based Crown Bioscience acquires Nottingham oncology spin-out.

Crown Bioscience has acquired University of Nottingham spin-out Preclinical Oncology Services (PRECOS) for an unspecified sum.

The deal will add PRECOS’ expertise in oncology pre-clinical research and development services to Crown. As a result, the California-based firm will become one of the world’s largest suppliers of oncology services with bases in the US, the EU, and Asia.

Jean-Pierre Wery, president of Crown Bioscience said: “The acquisition represents the next step in expanding the range of specialized services we offer pharmaceutical…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?